|
Volumn 65, Issue 4, 2005, Pages 577-
|
5-Lipoxygenase as a putative mechanism of NSAID-related psychiatric adverse events
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARACHIDONATE 5 LIPOXYGENASE;
ARACHIDONIC ACID;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
LEUKOTRIENE;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
ALLELE;
ANXIETY DISORDER;
ARTERY INTIMA PROLIFERATION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CAROTID ARTERY;
CLINICAL TRIAL;
DEPRESSION;
GENE EXPRESSION REGULATION;
GENE FUNCTION;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
GENOTYPE;
HEART INFARCTION;
HUMAN;
LETTER;
MENTAL DISEASE;
RISK ASSESSMENT;
SIDE EFFECT;
STROKE;
UPREGULATION;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARACHIDONATE 5-LIPOXYGENASE;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
MENTAL DISORDERS;
MICE;
RISK FACTORS;
|
EID: 16344366706
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-200565040-00009 Document Type: Letter |
Times cited : (3)
|
References (6)
|